VEGF/VEGFR inhibitors

Alymsys 100 mg/4 mL (25 mg/mL) vial Images

Generic Name: bevacizumab

This medication has been identified as Alymsys 100 mg/4 mL (25 mg/mL) vial. It is supplied by Amneal Pharmaceuticals LLC.

Alymsys is used in the treatment of Colorectal Cancer; Glioblastoma Multiforme; Cervical Cancer; Fallopian Tube Cancer; Non-Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Alymsys 100 mg/4 mL (25 mg/mL) vial is not a controlled substance under the Controlled Substances Act (CSA).

Images

Alymsys (Bevacizumab [ bev-a-ciz-oo-mab ])-medicine-100 mg/4 mL (25 mg/mL) vial

Alymsys
Generic Name: bevacizumab [ bev-a-ciz-oo-mab ]
Imprint: medicine
Strength: 100 mg/4 mL (25 mg/mL) vial
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: VEGF/VEGFR inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 70121-1754
Inactive Ingredients:
Latest News
Related Drugs